Codiak BioSciences, Inc. - ESG Rating & Company Profile powered by AI
This article includes a Q&A table on Codiak BioSciences, Inc.. If you work at Codiak BioSciences, Inc. and you would like to use your ESG aseessment, please contact us. Comprehensive ESG analysis of Codiak BioSciences, Inc. can be reached by signing in.
Codiak BioSciences, Inc. in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.1; made up of an environmental score of 0.0, social score of 1.6 and governance score of 1.6.
1.1
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1779 | Taisho Pharmaceutical Holdings Co Ltd | 1.2 | Low |
| 1779 | VBI Vaccines Inc | 1.2 | Low |
| 1810 | Codiak BioSciences, Inc. | 1.1 | Low |
| 1810 | Captor Capital Corp | 1.1 | Low |
| 1810 | Century Therapeutics Inc | 1.1 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Codiak BioSciences, Inc. have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose current and historical energy intensity?
Sign up for free to unlockDoes Codiak BioSciences, Inc. report the average age of the workforce?
Sign up for free to unlockDoes Codiak BioSciences, Inc. reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose its ethnicity pay gap?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose cybersecurity risks?
Sign up for free to unlockDoes Codiak BioSciences, Inc. offer flexible work?
Sign up for free to unlockDoes Codiak BioSciences, Inc. have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Codiak BioSciences, Inc. conduct supply chain audits?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Codiak BioSciences, Inc. conduct 360 degree staff reviews?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose the individual responsible for D&I?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose water use targets?
Sign up for free to unlockDoes Codiak BioSciences, Inc. have careers partnerships with academic institutions?
Sign up for free to unlockDid Codiak BioSciences, Inc. have a product recall in the last two years?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose incidents of discrimination?
Sign up for free to unlockDoes Codiak BioSciences, Inc. allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Codiak BioSciences, Inc. issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose parental leave metrics?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose the pay ratio of women to men?
Sign up for free to unlockDoes Codiak BioSciences, Inc. support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Codiak BioSciences, Inc. reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Codiak BioSciences, Inc. involved in embryonic stem cell research?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose its waste policy?
Sign up for free to unlockDoes Codiak BioSciences, Inc. report according to TCFD requirements?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose energy use targets?
Sign up for free to unlockDoes Codiak BioSciences, Inc. disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Codiak BioSciences, Inc. have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Codiak BioSciences, Inc.
These potential risks are based on the size, segment and geographies of the company.
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12, an exosome therapeutic candidates, for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; exoASO-NLRP3 for multiple sclerosis, neuropathy, and neurodegeneration; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics, Washington University, Ragon Institute of MGH, MIT, and Harvard. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.